Schoenberg Mark 4
4 · UroGen Pharma Ltd. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-07-28+10,000→ 163,378 total - Sale
Ordinary Shares
2025-07-28$19.14/sh−5,149$98,552→ 158,229 total
Footnotes (3)
- [F1]Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.
- [F2]Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F3]Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.